Prodesse Files for FDA Clearance of Molecular Metapneumovirus Assay | GenomeWeb
NEW YORK (GenomeWeb News) – Prodesse has filed with the US Food and Drug Administration for 510(k) clearance of its real-time PCR-based Pro hMPV+ Assay for rapid detection of human metapneumovirus.
 
Prodesse said that the assay can provide accurate results in as little as three hours compared to days or weeks for non-molecular methods. hMPV was discovered in 2001 and causes acute respiratory illness. Its prevalence ranges from 6.6 percent to 12 percent annually of patients with symptoms of respiratory infection.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.